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The  technique  of electrospray  differential  mobility  analysis  (ES-DMA)  was  examined  as  a  potential
potency  assay  for  routine  virus  particle  analysis  in  biomanufacturing  environments  (e.g., evaluation  of
vaccines  and  gene  delivery  products  for lot  release)  in the  context  of  the  International  Committee  of
Harmonisation  (ICH)  Q2  guidelines.  ES-DMA  is  a rapid particle  sizing  method  capable  of  characterizing
certain  aspects  of  the  structure  (such  as  capsid  proteins)  and  obtaining  complete  size distributions  of
viruses and  virus-like  particles.  It was  shown  that  ES-DMA  can  distinguish  intact  virus  particles  from
degraded  particles  and  measure  the  concentration  of  virus  particles  when  calibrated  with  nanoparticleseywords:
lectrospray
ifferential mobility analyzer
irus
CH Q2
as phase electrophoretic molecular
of  known  concentration.  The  technique  has  a measurement  uncertainty  of  ≈20%, is linear  over  nearly
3  orders  of  magnitude,  and  has  a lower  limit  of  detection  of  ≈109 particles/mL.  This  quantitative  assay
was demonstrated  for non-enveloped  viruses.  It  is  expected  that  ES-DMA  will be  a useful  method  for
applications  involving  production  and  quality  control  of  vaccines  and gene  therapy  vectors  for  human
use.obility analysis (GEMMA)
. Introduction
Evaluating the titer (concentration) of viral products as part
f a lot release protocol is a key quality control step essential
o ensuring their efficacy and safety (ICH Expert Working Group,
005). Although the specific tests comprising the lot release pro-
ocol are prescribed individually for each product as appropriate
or each case, the assays and instruments used to evaluate the
dentity, composition and potency of viral products must meet
tandards established by the International Committee on Har-
onisation (ICH) (ICH Expert Working Group, 2005). Specifically,
ICH Q2 Validation of Analytical Procedures: Text and Methodol-
gy” indicates that a quantitative assay must be evaluated based
n seven criterion, namely; specificity, linearity, range, accuracy,
recision, robustness, and system suitability testing (ICH Expert
orking Group, 2005).
Common tests used to identify the concentration and compo-
ition of viruses includes transmission electron microscopy (TEM),
canning electron microscope (SEM), analytical ultracentrifugation
∗ Corresponding author at: 2125 Glenn L. Martin Hall, Building 088, University of
aryland, College Park, MD 20742 United States. Tel.: +1 301 405 4311;
ax: +1 301 314 9477.
E-mail address: mrz@umd.edu (M.R. Zachariah).
166-0934/$ – see front matter ©  2011 Published by Elsevier B.V.
oi:10.1016/j.jviromet.2011.09.012© 2011 Published by Elsevier B.V.
and dynamic light scattering. Although each of these methods pos-
sesses particular strengths for evaluating viral products, they all
have disadvantages. For example, while TEM provides high reso-
lution images, it is expensive, relatively slow, and artifacts can be
introduced from electron beam damage, sample preparation, and
biases in particle selection for quantitative analysis. In contrast,
dynamic light scattering is relatively fast and can analyze the sam-
ple in situ; however, it cannot accurately differentiate viral particles
differing by less than 10 nm in diameter or easily quantify virus par-
ticles either (Filipe et al., 2010). Resolving particles that are close
in size is an important criteria, as viral degradation often leads to
mixtures of intact and partially degraded viruses that can differ in
diameter by 10 nm or less.
The objective of this article was  to present ES-DMA (Fig. 1) as
a potential method for analysis in biomanufacturing environments
(e.g., evaluation of gene therapy produces, vaccines for routine lot
release, etc.) where relatively concentrated solutions of particles
20–200 nm in size are measured. The advantages of ES-DMA for
characterizing vaccines include its ability to provide a direct read-
out of particle size distributions, to measure rapidly statistically
significant populations of nanoparticles, and to detect changes in
nanoparticle diameter as small as 0.3 nm,  far below the size of the
smallest viruses (Tsai et al., 2008, 2009). In addition, viruses can
be identified based on particle size, thereby ruling out contami-
nating adventitious agents unless they are of the same size. Size
202 S. Guha et al. / Journal of Virological 
Fig. 1. ES-DMA system consisting of an electrospray-charge neutralizer to produce
aerosolized, singly charged virus and protein particles, a differential mobility ana-
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cyzer to separate them by their charge-to-size ratio (because electrical and drag
orces act on them, Fe and Fd, respectively), and a condensation particle counter to
numerate the size-selected viruses or proteins.
easurement by ES-DMA also does not rely on host-specific infec-
ivity or species specific qPCR primers.
Over the last decade, ES-DMA has been applied broadly to char-
cterize phage and virus-like particles. For example, a number of
tudies measured the size of both large and small viruses (Bacher
t al., 2001; Bothner and Siuzdak, 2004; Wick et al., 2005; Hogan
t al., 2006; Thomas et al., 2004; Cole et al., 2009; Kaddis et al.,
007; Laschober et al., 2008; Pease et al., 2009; Wick et al., 2007).
sing ES-DMA size distributions Pease et al. (2011) determined the
ymmetry and number of proteins per capsid for PR772 (Family
ectiviridae, Genus Tectivirus), a biosafety level 1 (BSL1) simulant of
denovirus. Lute et al. (2008) and Wick et al. (2007) extended ES-
MA analyses to viruses of particular interest to biomanufacturers
nd filter firms by characterizing the size distributions of murine
inute virus (Family Parvoviridae, parvovirus) and the BSL1 mod-
ls, PP7 (Family Leviviridae,  Genus Levivirus) and X174 (Family
icrovaridae, Genus Microvirus)  (Wick et al., 2007) used in virus
ltration studies (Lute et al., 2008) and in the Parenteral Drug Asso-
iation’s (PDA) new nomenclature standards for small and large
irus retentive filters. Wick et al. (2005) demonstrated that ES-
MA is sufficiently gentle to enveloped viruses such as alphavirus
Family Togaviridae) although there was some loss of structure
n murine hepatitis virus (Family Coronaviridae, Genus Corona-
irus), and sendai rodent virus (Family Paramyxoviridae, Genus
espirovirus). Using a novel recombinant virus-like particle as a test
rticle, Pease et al. (2009) recently compared ES-DMA size distribu-
ions to those of TEM and asymmetric flow field-flow fractionation
nd found good agreement among the techniques for particle quan-
itation. Furthermore, it was shown that icosahedra viruses remain
nfectious following electrospray (Hogan et al., 2006; Siuzdak et al.,
996; Thomas et al., 2004), though long tubular viruses appear to
ose structural integrity and infectivity in the electrospray. Overall,
his technique has the potential to analyze many types of viruses.
ES-DMA operates at atmospheric conditions thereby intro-
ucing a drag force on the charged particle. Thus, unlike mass
pectrometry which separates particles on the basis of their mass-
o-charge ratio, the DMA  separation is based on charge-to-size
atio. In the size regime of relevance to these studies, the DMA  “size”
etric of separation is the projected areas orthogonal to the princi-
le axes of the particles, which for a spherical particle is simply the
rea of a circle of the same radius (Pease et al., 2010). Like mass-
pectrometry, electrospray is used for sample delivery; however, in
S-DMA, droplets are immediately neutralized by passage through
 radioactive source (Po-210) positioned at the exit of the electro-
pray. These droplets, some of which contain particles of interest,
ry as they pass through the neutralizer, leaving 5–20% of the dry,
erosolized particles with a single positive charge (Weidensohler,
988). Scanning through a range of charge-to-size ratios gives a
etailed size distribution for the virus containing solution. ES-DMA
an be used to size particles ranging from three to hundreds ofMethods 178 (2011) 201– 208
nanometers in diameter and differentiate spherically equivalent
sizes as small as 0.3 nm at its highest reported resolution (Tsai et al.,
2008, 2009).
In the following sections, ES-DMA is evaluated based on ICH Q2
principles after the preparation protocols for the different materials
and the operating conditions for ES-DMA are presented.
2. Materials and methods
2.1. Test article preparation
Phage PP7 and its host Pseudomonas aeruginosa were obtained
from the ATCC (Manassas, VA; accession numbers 15692-B4 and
15692). Coliphage PR772 and host E. coli strain K-12 J-53-1 were
obtained from the Félix d’Hérelle Reference Center for Bacterial
Viruses (Université Laval, Québec, Canada). These bacteriophage
models were used instead of actual mammalian viruses because
they can be easily grown to high titer and can be prepared and stud-
ied under BSL1 conditions. Stocks were prepared by CsCl gradient
ultracentrifugation methods, and live intact phages were enumer-
ated by plaque assays using their respective hosts, as described
elsewhere (Lute et al., 2004, 2007). The phages were then dialyzed
into 2.0 mmol/L ammonium acetate, pH 7.4, in preparation for the
electrospray. Studies showed that short term storage (≈months)
in this buffer system did not significantly impact phage infectiv-
ity (results not shown). For PR772 the dialyzed sample at an initial
concentration of 1.5 × 1012 plaque forming units/mL (pfu/mL) was
diluted to prepare a serial dilution of 4×, 10×,  50×,  500× and 5000×
and have been henceforth referred to as PR772a, PR772b, PR772c,
PR772d and PR772e, respectively. For PP7, dialysis a parent stock
resulted in an initial concentration of 2.5 × 1013 pfu/mL. Then a fifty
times dilution from the above stock was  prepared from which serial
dilutions of 2×, 5×, 50×,  500× and 1000× were prepared and have
been henceforth referred to as PP7a, PP7b, PP7c, PP7d and PP7e,
respectively.
Analysis in this article was limited to viral particles in solutions
in which nonvolatile salts, surfactants, or other materials present
in formulation buffers had largely been removed. The presence of
these species were found to cause clogging of electrospray cap-
illaries, destabilizing the electrospray and resulting in noisy size
distributions. Other factors that affect the stability of the electro-
spray include capillary diameter, ionic strength outside of a specific
conductivity window, and protein or buffer species that affect the
surface tension.
To create partially degraded test samples, dialyzed PR772 and
PP7 samples were placed in 1.5 mL  protein low binding centrifuge
vials (Eppendorf North, Westbury, NY, USA, #022431081) and
heated using a BLOK heater (Labline Instruments Inc, Melrose Park,
IL, USA, #2003) to temperatures from 50 ◦C to 80 ◦C. The sam-
ples were heated within 2 min  to the desired temperature, and
maintained within ±1.0 ◦C as measured by a type K thermocouple
(Omega, Stamford, Connecticut, USA) inserted directly into sam-
ple vials via holes punctured through their caps. After 30 min the
samples were removed from the BLOK heater. Control samples for
comparison were held at ambient temperature (25 ◦C) for 30 min.
For infectivity assays, dilutions of the virus stocks and heat
treated samples were prepared and added to mid-log-phase host
and liquefied top agar, which was  spread over tryptic soy agar
plates.
2.2. Buffer preparationElectrospray buffer was prepared by adding 0.77 g of ammo-
nium acetate (Sigma–Aldrich, St. Louis, MO,  #631-61-8) to 0.5 L of
deionized water (18 M/cm, Barnestead nanopure UV system) and
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djusting to the desired pH using ammonium hydroxide (Baker,
hillipsburg, NJ, #9721-01).
.3. Gold nanoparticles preparation
For quantitative number concentration calibration of the ES-
MA, gold nanoparticle reference standards were used. One
illiliter aliquots of as received 20 nm and 60 nm Ted Pella gold
nitially at particle concentrations of 7.0 × 1011 particles/mL and
.6 × 1010 particles/mL were centrifuged for 20 min  and 10 min,
espectively, at 13,200 rpm which were subsequently concen-
rated to prepare stock concentrations of 3.4 × 1012 particles/mL
nd 2.6 × 1011 particles/mL for 20 nm and 60 nm samples, respec-
ively. Two different sizes were selected because the sensitivity of
S-DMA depends on size, with sensitivity increasing with particle
ize. Serial dilutions of 2, 4, 8, 16, 32, and 64 times for the 20 nm
nd 2, 4, 8, and 16 times for 60 nm were then prepared from this
tock.
.4. ES-DMA operation and data analysis
Centrifuge vials containing the samples for ES-DMA were
nserted into the pressure chamber of an electrospray aerosol gen-
rator (TSI Inc., USA, #3480). A pressure of 3.7 psi (26 kPa) in the
ead space drove flow (≈66 nL/min) through a 25 m inner diam-
ter capillary at the exit of which a voltage was  tuned to form the
eniscus into a conical shape Taylor cone. The current observed in
he electrospray typically varied from 290 nA to 340 nA. A stream of
as, consisting of 1.1 L/min of air, flowed coaxially with the capillary
o carry the highly charged droplets into a bipolar charge neutral-
zer (Po-210) placed at the exit of the ES, to produce a stream of
articles with a known charge distribution (Weidensohler, 1988;
im et al., 2005). These charged aerosolized virus particles were
hen passed into the differential mobility analyzer. The DMA  (TSI
nc., USA, #3080) was operated with a sheath flow of 30 L/min
or PP7 or 10 L/min for PR772. Because the trajectory of the virus
articles is controlled by balancing the electrical and drag forces
cting on them, only those with a selected charge-to-size ratio, for
he applied electric field chosen, passed into the collection slit for
ounting. By stepping through different electric fields, a size dis-
ribution was  obtained, in increments of 0.2 nm (Wang and Flagan,
990). The size reported in this article is the spherically equivalent
ize obtained using Stokes drag law corrected with the velocity slip
orrection (Hinds, 1999).
Particles (viruses and capsid proteins) exiting the DMA  were
ounted using a condensation particle counter (CPC) (TSI Inc., USA,
3025A) (Kesten et al., 1991). Flow into the CPC consisted of
.0 L/min exiting the DMA  supplemented by 0.5 L/min of ambient
ir filtered through a HEPA filter to allow the CPC to operate in its
igh flow mode. Within the CPC, particles passed through a satu-
ated butanol environment and grew by condensation into droplets
everal micrometers in size, which were counted individually by
ight scattering.
The raw ES-DMA distributions present counts or number den-
ity of positively charged particles versus the spherically equivalent
obility diameter. The positively charged virus particles measured
epresented only a fraction of all of the viruses emerging from the
lectrospray. The total gas phase particle count for each size was
btained by dividing the number of positively charged viruses by
he fraction of positively charged viruses, which depends primar-
ly on the particle size (Weidensohler, 1988). As described in a
revious publication, an “overlap correction” was also applied to
revent double counting of essentially the same particles (Pease
t al., 2010).
Gold nanoparticles (Ted Pella) prepared in ammonium acetate
uffer (Tsai et al., 2008) or 60 nm polystyrene latex particles (NISTMethods 178 (2011) 201– 208 203
SRM® 1963) were used as system suitability standards to confirm
operation of the instrumentation (Lall et al., 2009).
2.5. Gold calibration approach
In order to correlate gas phase concentration with liquid phase,
Cole et al. (2009) used known concentrations of gold nanoparticles
to calibrate the ES-DMA system to determine the concentration of
virus particles. The ratio of particles in solution and signal inten-
sity from the DMA  gave the response function of the DMA  system.
The response function was  then used to obtain virus concentra-
tion in solution. Virus concentration values determined this way
were found to be in good agreement with amino acid analysis (Cole
et al., 2009). A similar protocol was used in this article to determine
concentrations of PP7 and PR772.
Two  different gold nanoparticles sizes of known concentra-
tions were selected; nominally 20 nm and 60 nm,  to approximate
particles close in size to PP7 and PR772. Serial dilutions of 20 nm
citrate stabilized Ted Pella gold nanoparticles, as mentioned in
Section 2.3,  were created to obtain a response function for the ES-
DMA of 6.21 × 10−8 ± 4.6 × 10−9 (particles/cm3)/(particles/mL)
for PP7 where the response function is defined as the
ratio of the concentration measured in gas phase using
ES-DMA and the actual particle concentration in solu-
tion. Similarly using 60 nm particles, a response function of
9.15 × 10−8 ± 8.0 × 10−9 (particles/cm3)/(particles/mL) for PR772
was obtained. The difference in response functions for PP7 and
PR772 was  likely due to different ES-DMA settings and operational
parameters used (e.g., particle size dependent diffusional losses).
2.6. TEM characterization
TEM analysis employed a standard negative staining procedure
performed by JFE Enterprise (Brookeville, MD). Briefly, a drop of
0.01% of BSA was  placed on a formvar/carbon coated grid and
wicked off with filter paper. Then 2.0 L of the virus was  applied
on the coated grid and allowed to air-dry. The grid was washed
with distilled water twice and air dried. Subsequently, 10 L of
1.0% uranyl acetate was placed on the grid, allowed to stain for 30 s,
wicked off and then allowed to air dry again before TEM imaging.
3. Results
Like any assay, ICH Q2 should be used to validate ES-DMA for any
particular application, e.g., testing particle size distributions of vac-
cines or gene therapy vectors. According to ICH Q2, “the objective
of validation of an analytical procedure is to demonstrate that it is
suitable for its intended purpose.” This guidance recommends eval-
uation of a quantitative assay along seven lines of inquiry; namely
specificity, linearity, range, accuracy, precision, robustness, system
suitability, limit of detection (LoD) and limit of quantitation (LoQ).
In the remainder of this article, the phages were considered as
though they were the models for industrially relevant virus prepa-
rations of interest and the performance of ES-DMA was evaluated
as a quantitative assay relative to ICH Q2 criteria to measure the
viral analyte present in the sample.
3.1. Specificity
Demonstration of specificity confirms the ability of an assay
to distinguish the species of interest within a sample from
extraneous material or closely related species such as con-
taminating adventitious viruses. ICH Q2 states that specificity
must “assess unequivocally the analyte in the presence of
204 S. Guha et al. / Journal of Virological Methods 178 (2011) 201– 208
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The linearity, accuracy and precision of ES-DMA for measuring
the concentration of virus particles were determined. Five dif-
ferent dilutions each of PP7 and PR772 were prepared and their
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Fig. 3. ES-DMA aerosol number density, N, versus solution concentration,
C,  for PP7 and PR772. The linear fits were log10(N) = 0.9774 log10(C) − 5.6782
with R2 = 0.9995(denoted by long blue dash) for PR772 and
log10(N) = 1.09 log10(C) − 6.1662 (denoted by short purple dash) with R2 = 0.9993 for
PP7.  The linear fits for 60 nm and 20 nm Au were log10(N) = 0.9425 log10(C) + 7.2533ig. 2. (a) ES-DMA size distributions for PR772 and TEM images of PR772 (b) untrea
nd  TEM images of PP7 (f) untreated and (g) heated for 30 min  to 60 ◦C.
omponents. . .including impurities, degradants, matrix, etc.” (ICH
xpert Working Group, 2005).
ES-DMA can differentiate intact virus particles from impuri-
ies associated with degradation products, e.g., capsids that are
artially or completely degraded. To model such impurities, virus
articles were thermally degraded for 30 min  at temperatures up
o 70 ◦C, and ES-DMA size distributions and TEM images were
btained for PR772 and PP7 before and after thermal treatment
Fig. 2). ES-DMA size distributions for PR772 (Fig. 2a) showed
wo peaks corresponding to degraded viruses (≈50 nm)  at 70 ◦C
nd intact viruses (≈60 nm)  at ambient temperature and 60 ◦C.
he full size distribution (Fig. S1)  also included a third peak at
8.0 nm which was assigned to P3 trimers (Lute et al., 2004)
ased on Bacher et al’s (2001) molecular weight correlation. Larger
tructures that were likely aggregates of the capsid proteins also
ppeared between 10 nm and 20 nm and increased in intensity with
ncreasing incubation temperatures (Fig. S1).  The specificity of ES-
MA was confirmed by comparing ES-DMA size distributions to
EM micrographs. The TEM micrographs showed a similar trend
f intact particles at ambient conditions, partially degraded parti-
les at 60 ◦C and then completely degraded particles at 70 ◦C with
redominantly intact virus particles (Fig. 2b) and degraded parti-
les (Fig. 2c and d). Some particles of size 100–200 nm were seen
Fig. 2d) but possibly were below the limit of detection of the ES-
MA, for only a few were found in the TEM micrographs.
The ES-DMA size distribution of PP7 (Fig. 2e) showed puta-
ively intact virus particles (≈23 nm)  and degraded capsid proteins
r their aggregates at smaller sizes (≈10 nm)  that increased in
oncentration with incubation temperature. Similarly, the TEM
icrographs, at ambient conditions showed no difference from
ample heated at 60 ◦C (Fig. 2f); however, in contrast to ES-DMA
ata, there was little evidence of degraded capsids proteins. Nev-
rtheless, the agreement confirmed ES-DMA’s ability to identifyd heated for 30 min  to (c) 60 ◦C and (d) 70 ◦C. (e) ES-DMA size distributions for PP7
specifically intact and partially degraded capsids or aggregates of
capsid proteins.
3.2. Precision, linearity and accuracywith  R2 = 0.9989 and log10(N) = 0.9439 log10(C) + 7.4424 with R2 = 0.9996, respec-
tively. The error bars, if not visually apparent, were smaller than the symbols and
were from samples run in triplicate. The long (blue) and short (purple) dashed lines
guide the eyes. (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
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oncentrations were determined by a plaque-based assay and ES-
MA. For virus particle concentration measurement, the PP7 peak
ncluded counts from 21.0 nm through 26.8 nm and the PR772 peak
ncluded counts from 55.0 nm to 67.8 nm.  The mean mobility diam-
ter of PR772 and PP7 were determined to be 62.1 nm ± 0.4 nm
nd 23.8 ± 0.3 nm respectively for size distributions obtained in
riplicate. All linearity studies were performed using the same cap-
llary to rule out any differences arising from different capillaries.
S-DMA gas phase number density as a function of solution concen-
ration of PR772 and PP7 was plotted over a solution concentration
ange from 4.48 × 109 particles/mL to 5.15 × 1012 particles/mL and
.12 × 1010 particles/mL to 9.9 × 1012 particles/mL for PR772 and
P7, respectively (Fig. 3). The values of the exponents for PR772
nd PP7 were determined to be 0.9974 and 1.09, respectively, indi-
ating linearity (Fig. 3, caption). R2 values in excess of 0.99 for both
he cases indicated that the fit was good.
ES-DMA characterizes two properties of particles: size and num-
er concentration. The accuracy of ES-DMA for determination of
ize were established for spherical and nearly spherical particles
lsewhere (Tsai et al., 2009; Mulholland et al., 2006). Accuracy of ES-
MA for determination of concentration can be established usually
y comparing results with another orthogonal technique although
ethods are not always directly comparable as given below.
To relate ES-DMA counts to concentration of virus particles
n solution, ES-DMA was calibrated by analyzing gold nanoparti-
les of known concentration as was discussed in Section 2.5.  The
bsolute liquid phase virus concentration was also determined by
S-DMA (column 4, Table 1). Particle measurements were 11-15
old (PR772) and 22-42 fold (PP7) greater than their infectivity
Table 1), showing that these preparations were 2–10% infectious
n agreement with previous results (Cole et al., 2009).
In order to compare the inter-day precision with intra-day pre-
ision, samples PR772c and PP7b were measured repeatedly on an
ndividual day to determine the repeatability and across several
ays to measure the intermediate precision. The data was found to
all within relatively narrow bands (Table 2). It was observed that
or both PP7 and PR772 the intra-day variations were smaller than
he inter-day variation, as is typical for precision studies. The larger
nter-day variation was expected because over this time period, the
S-DMA system was shut down (which consists of switching off the
S, sheath flow and the CPC) and restarted which may  have caused
odest differences in flow rates or may  have affected the perfor-
ance of the DMA  or the CPC. In addition, the effect of changing
apillaries was also studied, an issue addressed in greater detail in
ection 3.5.  It should be pointed out that the gas phase repeatability
ounts obtained with the ES-DMA for PP7b in Table 1 and Table 2
re different as they were obtained on different days.
.3. Detection and quantitation limits
The limits of detection and quantitation were determined
sing the signal-to-noise method indicated in ICH Q2 Sections
.2 and 7.2. First, the CPC baseline was determined by elec-
rospraying ammonium acetate buffer through a capillary and
y obtaining size distributions of this control buffer from 2 nm
o 45 nm for PP7 or 2 nm to 75 nm for PR772. Then, the base-
ine where PP7 (21 nm to 26.8 nm)  and PR772 (55 nm to 68 nm)
ould appear were summed to obtain the limit of detection
or these viruses, respectively. This was repeated in triplicate
nd the uncertainty in CPC (aerosol phase) counts in the base-
ine was determined to be 45 particles/cc ± 14 particles/cc and
 particles/cc ± 2 particles/cc for the measured size range of PP7
nd PR772, respectively (data not shown). The product of the mea-
ured uncertainty with the average response functions of 20 nm
nd 60 nm Au nanoparticles gives a measure of the liquid phase
oise level for PP7 and PR772, respectively. Further, since ICHMethods 178 (2011) 201– 208 205
Q2 specifications for LoD require a signal-to-noise ratio of 3:1,
the liquid phase noise was multiplied by three to obtain LoDs of
7.3 × 108 particles/mL for PP7 and 2.3 × 108 particles/mL for PR772,
respectively. Expressing these values as plaque assay LoDs (pfu/ml)
yielded 2.3 × 107 pfu/mL (assuming particle:infectivity ratio of
≈32) and 1.7 × 107 pfu/mL (assuming particle:infectivity ratio ≈14)
for PP7 and PR772, respectively. These values were distinctly higher
than the LoD of approximately 106 infectious virus/mL determined
by Hogan et al. (2006) for bacteriophage viruses although they did
not report a baseline uncertainty.
The limit of quantitation (LoQ) was determined using a sim-
ilar signal-to-noise method. For the LoQ, all steps were similar
to that described for LoD except the last one where the liquid
phase noise in the above data was  multiplied by ten instead of
three as per ICHQ2, resulting in LoQs of 2.5 × 109 particles/mL and
7.5 ×108 particles/mL for PP7 and PR772, respectively. Expressing
the concentration in terms of pfu/mL, the LoQ were determined
to be 7.7 ×107 pfu/mL and 5.6 × 107 pfu/mL for PP7 and PR772,
respectively.
3.4. Range
ICH Q2 also requires a determination of the dynamic range of the
instrument. The LoQ as specified above defined the lower end of the
range. The instrument has an upper limit of 106 particles/cm3 (in
the aerosol phase), but any highly concentrated solution can always
be diluted to reduce the concentration to the linear region of the
instrument. Thus, the upper range can be defined by the highest
particle titer in a test particle.
3.5. Robustness
For ES-DMA the primary factors that influence size and concen-
trations are ambient temperature variations; fluctuations of the gas
flow in the electrospray, DMA  and CPC; performance of the neu-
tralizer; and variation in capillaries. ICH Q2 calls for investigation
of such parameters under the rubric of robustness. Ambient tem-
perature variations may  influence the gas flows in the ES, the DMA
as well as the CPC. The performance of the DMA depends on the
relative rates of a carrier gas in the DMA  and the analyte carrier
gas (Tsai et al., 2008, 2009) that arrives from the ES. Any changes in
these flows can cause apparent changes in size and concentration of
the particles of interest. Additionally, the flow rates may  also vary
slightly over time even without temperature changes. Each change
may  cause variation in counts and size obtained by ES-DMA assay
over several hours on the same day or over several days as has
been addressed under the rubric of “repeatability” and “intermedi-
ate precision” (Section 3.2). Further, the neutralizing source used
for charge reduction (Po-210) has a half-life of 138 days, and should
be operated under conditions of excess alpha radiation to neutral-
ize the ionized particles. Extended operation of the same Po-201
source past one year can lead to a degraded charging efficiency.
Capillaries in the electrospray often need to be changed, because
of clogging from either very large impurities (micron sized) in the
solution, or from deposition of particles on the electrospray tip with
time, both of which affects ES-DMA concentration measurements.
To study this variation, the PP7 and PR772, size distributions were
obtained using three different capillaries on the same day. For PP7
and PR772 the mean diameters obtained were 23.7 nm ± 0.1 nm
and 61.9 nm ± 0.3 nm in conjunction with linearity studies, which
implied that changing the capillaries did not affect the size. How-
ever, concentrations determined by the ES-DMA were found to vary
with change of capillaries (last two  rows, Table 2). These variations
were found to be comparable to the intermediate precision, i.e.,
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Table 1
ES-DMA as compared to plaque assay.
Plaque assay derived
concentration (pfu/mL)
ES-DMA gas-phase particle
counts (particles/cm3)a
ES-DMA (concentration in
solution particles/mL)
Ratio (ES-DMA par-
ticles/mL)/(pfu/mL)
PR772a 3.75 × 1011 471700 ± 96400 5.15 × 1012 14
PR772b 1.5 × 1011 154400 ± 5100 1.69 × 1012 11
PR772c 3.00 × 1010 38300 ± 2300 4.18 × 1011 14
PR772d 3.00 × 109 3800 ± 20 4.13 × 1010 14
PR772e 3.00 × 108 400 ± 110 4.48 × 109 15
PP7a  2.50 × 1011 614800 ± 7300 9.90 × 1012 40
PP7b 1.00  ×1011 258500 ± 6600 4.16 × 1012 42
PP7c 1.00  × 1010 23700 ± 330 3.81 × 1011 38
PP7d  1.00 × 109 1700 ± 110 2.69 × 1010 27
PP7e  5.00 × 108 700 ± 20 1.12 × 1010 22
a Samples run at least in duplicate.
Table 2
Repeatability, intermediate precision and capillary variation statistics for ES-DMA.
Average
(particles/cc)
Standard deviation
(particles/cc)
Coefficient of
variation
Confidence
interval*,** (%)
Repeatability PR772c 38,300 2300 0.060 5.7
Repeatability PP7b 2,69,300 13,500 0.050 4.8
Intermediate precision PR772c 33,270 6950 0.209 19.8
Intermediate precision PP7b 2,65,200 17,400 0.066 6.2
Capillary variation PR772c 31,600 3200 0.101 9.6
Capillary variation PP7b 2,71,140 34,750 0.128 12.2
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** Calculations done at 90% confidence level for samples run in triplicate.
hanging capillaries on one day had as much effect as did other
ay-to-day factors (such as flow and temperature fluctuations).
. Discussion
Manufacturers routinely characterize vaccines and gene deliv-
ry products when releasing lots or performing stability studies.
etermining the purity of final product and assessing concentration
t various stages of product processing are of paramount inter-
st. While techniques such as TEM and dynamic light scattering
an be used, drawbacks include long analysis times (TEM), skew-
ng of size for multimodal distributions (dynamic light scattering)
nd dependence of results on infectivity (plaque assays). Other
haracterization techniques such as antigen detection and nucleic
cid detection and amplification are also popular but they either
equire specific antibodies or high concentrations (EPIDI, 2009).
lso, plaque-forming assays cannot distinguish between a single
irus or an aggregate of several viruses which could potentially dis-
ssociate upon administration to humans and cause an over dose
alloy (2010).  MS  is gaining popularity for characterization Ding
t al. (2007),  but has been primarily applied to analysis of proteins
f viruses (Davison and Davison, 1995; Krokhin et al., 2003; Yao
t al., 2002) and rarely for entire capsids because of their large
izes (>1 MDa) resulting in high m/z  ratios (Tito et al., 2000). Also,
S spectra can be complex and size distributions can be difficult
o interpret because of multiple charging of particles (Tito et al.,
000).
In contrast, ES-DMA is a near real time method that operates at
tmospheric pressure, and can resolve the whole size distribution
rom capsid proteins to the whole virus as has been demonstrated in
ection 3.1. ES-DMA can achieve this objective by correlating iden-
ity with size. Thomas et al. (2004) has shown that the components
f mixtures of very similar sized viruses can be distinguished based
n size by ES-DMA. For example, they differentiated MS2  from
YMV based on a 4.3 nm size difference. Even though a database
orrelating size with identity has not yet been assembled usingES-DMA yet, a broad range of viruses can be distinguished based
on their distinct mobility diameters as discussed in Section 1.
It is possible that two or more viruses may  overlap in size such
as MS2  and PP7 or HRV and GD7, making positive identification
and complete discrimination difficult despite the subnanometer
resolution (Tsai et al., 2008) of ES-DMA. However, in the case of
industrial virus production, risk mitigating factors, such as stock
characterization and adventitious agent testing, lower the risk of
cross contamination of the widely different viruses.
To make the ES-DMA conducive to biomanufacturing, ES-DMA
was evaluated in the context of ICH Q2. The ratio of particles/mL
to pfu/mL for a given virus remained approximately constant as
a function of decreasing virus concentration (Table 1). This sug-
gested that the ES-DMA behaved linearly for the concentration
range examined. However, the ES-DMA and plaque assay data did
not yield the same counts (Table 1), which implied that not all phage
particles were infectious such that a direct comparison to infectivity
data led to a 10–40 fold disparity in the measured values, a com-
mon  observation in virology when comparing the infectivity assay
to methods that physically count particles (Xu and Brorson, 2001;
Brorson et al., 2002). This discrepancy between the plaque assay
and the ES-DMA measured concentrations presumably involves
several factors. ES-DMA is a physical measurement and counts all
virus particles whether “live” or “dead”, while the plaque assay is
infectivity count. To be infectious, a phage must land on the bacte-
ria, penetrate the cell membrane, take over the cellular machinery,
and then make copies of itself and finally lyse the bacteria. Each of
these processes has an efficiency of less than 100% thus a 1:1 parti-
cle to infectivity ratio is rarely achieved for any type of virion. This
also explains why  the LoDs and LoQs had different limits depend-
ing on whether they were expressed with respect to particles/mL
or pfu/mL. The plot of linearity (Fig. 3) showed that the data did
not extrapolate through the origin, an observation consistent with
that of Hogan et al. (2006) for MS2, T2, and T4 viruses suggesting
possible variability in the plaque assay measurements or dif-
ferences in depositional losses that arise from particles sticking
to surfaces (with smaller particles showing a greater propensity
ogical 
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o stick because Brownian diffusion is more) which may  be
ize and species specific. PP7 gas phase counts obtained with
he ES-DMA started to deviate from linearity at concentra-
ions below ≈1010 particles/mL perhaps because of imprecision at
he LoD.
Concentration measurements with ES-DMA yielded an uncer-
ainty of ≈10–20% (obtained by dividing the standard deviation
ith the average in Table 2), a value close to that reported in a previ-
us study (Cole et al., 2009) and slightly lower than that of the virus
nfectivity assay, which has an uncertainty of up to ≈30% (unpub-
ished observations). Additional advantages of ES-DMA compared
o infectivity assays include faster analysis time (minutes compared
o a day for plaque assay) and that the genetic sequence of the virus
r a viral host is not required for analysis.
The LoD was found to be size dependent. As indicated by Hinds
1999),  deposition losses due to particle diffusion increase strongly
s the particle size decreases. These losses may  occur in the neutral-
zer, DMA, entrance to the CPC, or all the intermediate connective
ubings. Therefore, it is unsurprising that the LoD for PP7 would
odestly exceed that for PR772 solely due to diffusion deposition
osses.
In summary, as the first step towards potential industry use and
cceptance, ES-DMA was examined as a tool for vaccine and gene
herapy product characterization in the context of ICH Q2 guide-
ines. The ES-DMA characterizes both “alive” or inactivated viruses,
otentially tracks their degradation, and can resolve aggregated
pecies. Further ES-DMA is rapid, non-biologically based quan-
itative assay, effective for non-enveloped viruses, with a lower
etection limit of ≈109 particles/mL, and was found to meet the
equirements set forth by ICH Q2.
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